$370,000 of AECOM lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Appropriations for Defense and Military Construction for Fiscal Year 2026. Issues related to Base Realignment and Closure funding and policy. Issues related to Defense department contracting. Golden Dome program management. Issues related to Air Force facilities construction. Funding and policy for water resource investments. Appropriations to support Water Resources Development Act programs and projects. US Army Corps WIFIA program eligibility. US Army Corps Contracting issues. Investments and policy related to implementation of digital technologies in administration of environmental reviews and permitting. Funding and policy related to harmful algal bloom clean up. Issues related to federal facilities. Issues relating to international trade in engineering services. Issues related to U.S. Government international infrastructure development programs. Infrastructure projects in Latin America, Europe, Middle East. Disaster relief in Jamaica. FY 2026 Appropriations for Defense, Military Construction, Transportation HUD, Interior-EPA, Energy and Water, Homeland Security, and State, Foreign Operations. Funding, programs and projects pertaining to transportation and infrastructure investment, including funding for public transportation, rail and water, environmental programs and FEMA. Program requirements for the Department of State related to the ongoing conflict in Ukraine. Provisions related to harmful algal bloom mitigation. Provisions related to digital applications for NEPA environmental reviews and public engagement. Supplemental appropriations related to domestic disaster assistance. Funding for State Department infrastructure programs. Funding, programs and projects pertaining to transportation and infrastructure investment, including funding for aviation, highways, public transportation and rail. Issues related to train station improvements. Surface transportation authorization legislation. Legislation to support digital applications for NEPA environmental reviews and public engagement for the Federal Highway Administration, including HR 4621, Interactive Federal Review Act (H.R.4621/S.2319). Issues related to the digital delivery of 3D models of infrastructure project designs, including the SMART Infrastructure Act. Funding for FEMA and Disaster Relief efforts, including pre-disaster mitigation grants and Stafford Act policy. Supplemental appropriations for domestic disaster assistance. FEMA reform legislation, including H.R.4669, the FEMA Act of 2025. Flood mapping programs and legislation to reform the National Flood Insurance Program."
You can find more data on corporate lobbying on Quiver Quantitative.
ACM Insider Trading Activity
ACM insiders have traded $ACM stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $ACM stock by insiders over the last 6 months:
- TROY RUDD (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 2 sales selling 53,097 shares for an estimated $6,348,193.
- LARA POLONI (PRESIDENT) has made 0 purchases and 2 sales selling 17,533 shares for an estimated $1,701,134.
- DAVID Y. GAN (CHIEF LEGAL OFFICER) has made 0 purchases and 2 sales selling 15,502 shares for an estimated $1,514,889.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ACM Hedge Fund Activity
We have seen 299 institutional investors add shares of ACM stock to their portfolio, and 308 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ORION PORFOLIO SOLUTIONS, LLC removed 5,319,446 shares (-99.7%) from their portfolio in Q3 2025, for an estimated $694,028,119
- FIRST TRUST ADVISORS LP added 2,162,158 shares (+105.3%) to their portfolio in Q3 2025, for an estimated $282,096,754
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,086,071 shares (+78.8%) to their portfolio in Q3 2025, for an estimated $272,169,683
- AMUNDI removed 806,913 shares (-43.7%) from their portfolio in Q3 2025, for an estimated $105,277,939
- PRIMECAP MANAGEMENT CO/CA/ removed 684,889 shares (-7.2%) from their portfolio in Q3 2025, for an estimated $89,357,467
- UBS GROUP AG added 672,281 shares (+71.3%) to their portfolio in Q3 2025, for an estimated $87,712,502
- INVESCO LTD. added 618,205 shares (+14.2%) to their portfolio in Q3 2025, for an estimated $80,657,206
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ACM Analyst Ratings
Wall Street analysts have issued reports on $ACM in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 01/21/2026
- Truist Securities issued a "Buy" rating on 11/21/2025
- RBC Capital issued a "Outperform" rating on 11/20/2025
- Argus Research issued a "Buy" rating on 11/20/2025
- Barclays issued a "Overweight" rating on 11/20/2025
- Citigroup issued a "Buy" rating on 11/19/2025
- B of A Securities issued a "Buy" rating on 08/05/2025
To track analyst ratings and price targets for ACM, check out Quiver Quantitative's $ACM forecast page.
ACM Price Targets
Multiple analysts have issued price targets for $ACM recently. We have seen 9 analysts offer price targets for $ACM in the last 6 months, with a median target of $139.0.
Here are some recent targets:
- Steven Fisher from UBS set a target price of $143.0 on 01/21/2026
- Adam Seiden from Barclays set a target price of $100.0 on 12/22/2025
- Jamie Cook from Truist Securities set a target price of $126.0 on 12/18/2025
- Andrew Wittmann from Baird set a target price of $143.0 on 11/21/2025
- John Staszak from Argus Research set a target price of $135.0 on 11/20/2025
- Sabahat Khan from RBC Capital set a target price of $139.0 on 11/20/2025
- Andrew Kaplowitz from Citigroup set a target price of $152.0 on 11/19/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
